PCM
MGCD

Perkins Capital Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Perkins Capital Management’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-41,000
Closed -$519K – 148
2013
Q4 		$519K Hold
41,000
– – 0.35% 87
2013
Q3 		$449K Sell
41,000
-10,000
-20% -$89.9K 0.32% 84
2013
Q2 		$426K Buy
+51,000
New +$371K 0.34% 84

Other funds holding MGCD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
HAMF
Hatteras Alternative Mutual Funds Raleigh, North Carolina $221M AUM 39.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Perkins Capital Management's MGCD Position: Q1 2014 in Review

Perkins Capital Management sold out of MGC Diagnostics Corporation (MGCD) in Q1 2014, closing a stake of 41,000 shares — an estimated $519K sold.

Perkins Capital Management first reported a position in MGCD in Q2 2013 and held it in 3 quarters. The position peaked at $519K in Q4 2013. 22 funds tracked by Wall St. Rank hold MGCD as of Q1 2014.

  • Perkins Capital Management reported no remaining MGC Diagnostics Corporation position as of Q1 2014 after selling out during the quarter.
  • Perkins Capital Management sold 41,000 MGC Diagnostics Corporation shares in Q1 2014, an estimated $519K.
  • Perkins Capital Management first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 3 quarters.
  • Perkins Capital Management's MGC Diagnostics Corporation position peaked at $519K in Q4 2013.
  • 22 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2014.

Based on Perkins Capital Management's 13F filing for Q1 2014, filed 7 May 2014.